Medical Care

Global Extracellular Vesicle Therapy Market Research Report 2024

The global market for Extracellular Vesicle Therapy was valued at US$ 821 million in the year 2023 and is projected to reach a revised size of US$ 1637 million by 2030, growing at a CAGR of 10.4% during the forecast period.
Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.
North American market for Extracellular Vesicle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracellular Vesicle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracellular Vesicle Therapy in Cancer Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracellular Vesicle Therapy include FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracellular Vesicle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Vesicle Therapy.
The Extracellular Vesicle Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracellular Vesicle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracellular Vesicle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM Diosynth Biotechnologies
EV Therapeutics
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Segment by Type
Exosome-based
Microvesicle-based
Segment by Application
Cancer Treatment
Regenerative Medicine
Drug Delivery
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracellular Vesicle Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicle Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Exosome-based
1.2.3 Microvesicle-based
1.3 Market by Application
1.3.1 Global Extracellular Vesicle Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Treatment
1.3.3 Regenerative Medicine
1.3.4 Drug Delivery
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicle Therapy Market Perspective (2019-2030)
2.2 Global Extracellular Vesicle Therapy Growth Trends by Region
2.2.1 Global Extracellular Vesicle Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extracellular Vesicle Therapy Historic Market Size by Region (2019-2024)
2.2.3 Extracellular Vesicle Therapy Forecasted Market Size by Region (2025-2030)
2.3 Extracellular Vesicle Therapy Market Dynamics
2.3.1 Extracellular Vesicle Therapy Industry Trends
2.3.2 Extracellular Vesicle Therapy Market Drivers
2.3.3 Extracellular Vesicle Therapy Market Challenges
2.3.4 Extracellular Vesicle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicle Therapy Players by Revenue
3.1.1 Global Top Extracellular Vesicle Therapy Players by Revenue (2019-2024)
3.1.2 Global Extracellular Vesicle Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Extracellular Vesicle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicle Therapy Revenue
3.4 Global Extracellular Vesicle Therapy Market Concentration Ratio
3.4.1 Global Extracellular Vesicle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicle Therapy Revenue in 2023
3.5 Global Key Players of Extracellular Vesicle Therapy Head office and Area Served
3.6 Global Key Players of Extracellular Vesicle Therapy, Product and Application
3.7 Global Key Players of Extracellular Vesicle Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracellular Vesicle Therapy Breakdown Data by Type
4.1 Global Extracellular Vesicle Therapy Historic Market Size by Type (2019-2024)
4.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Type (2025-2030)
5 Extracellular Vesicle Therapy Breakdown Data by Application
5.1 Global Extracellular Vesicle Therapy Historic Market Size by Application (2019-2024)
5.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Extracellular Vesicle Therapy Market Size (2019-2030)
6.2 North America Extracellular Vesicle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Extracellular Vesicle Therapy Market Size by Country (2019-2024)
6.4 North America Extracellular Vesicle Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicle Therapy Market Size (2019-2030)
7.2 Europe Extracellular Vesicle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Extracellular Vesicle Therapy Market Size by Country (2019-2024)
7.4 Europe Extracellular Vesicle Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicle Therapy Market Size (2019-2030)
8.2 Asia-Pacific Extracellular Vesicle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extracellular Vesicle Therapy Market Size (2019-2030)
9.2 Latin America Extracellular Vesicle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Extracellular Vesicle Therapy Market Size by Country (2019-2024)
9.4 Latin America Extracellular Vesicle Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicle Therapy Market Size (2019-2030)
10.2 Middle East & Africa Extracellular Vesicle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Diosynth Biotechnologies
11.1.1 FUJIFILM Diosynth Biotechnologies Company Details
11.1.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.1.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.2 EV Therapeutics
11.2.1 EV Therapeutics Company Details
11.2.2 EV Therapeutics Business Overview
11.2.3 EV Therapeutics Extracellular Vesicle Therapy Introduction
11.2.4 EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.2.5 EV Therapeutics Recent Development
11.3 Cellular Biomedicine Group
11.3.1 Cellular Biomedicine Group Company Details
11.3.2 Cellular Biomedicine Group Business Overview
11.3.3 Cellular Biomedicine Group Extracellular Vesicle Therapy Introduction
11.3.4 Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.3.5 Cellular Biomedicine Group Recent Development
11.4 Codiak BioSciences
11.4.1 Codiak BioSciences Company Details
11.4.2 Codiak BioSciences Business Overview
11.4.3 Codiak BioSciences Extracellular Vesicle Therapy Introduction
11.4.4 Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.4.5 Codiak BioSciences Recent Development
11.5 Coya Therapeutics
11.5.1 Coya Therapeutics Company Details
11.5.2 Coya Therapeutics Business Overview
11.5.3 Coya Therapeutics Extracellular Vesicle Therapy Introduction
11.5.4 Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.5.5 Coya Therapeutics Recent Development
11.6 Curexsys
11.6.1 Curexsys Company Details
11.6.2 Curexsys Business Overview
11.6.3 Curexsys Extracellular Vesicle Therapy Introduction
11.6.4 Curexsys Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.6.5 Curexsys Recent Development
11.7 Evox Therapeutics
11.7.1 Evox Therapeutics Company Details
11.7.2 Evox Therapeutics Business Overview
11.7.3 Evox Therapeutics Extracellular Vesicle Therapy Introduction
11.7.4 Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.7.5 Evox Therapeutics Recent Development
11.8 ExoCoBio
11.8.1 ExoCoBio Company Details
11.8.2 ExoCoBio Business Overview
11.8.3 ExoCoBio Extracellular Vesicle Therapy Introduction
11.8.4 ExoCoBio Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.8.5 ExoCoBio Recent Development
11.9 ILIAS Biologics
11.9.1 ILIAS Biologics Company Details
11.9.2 ILIAS Biologics Business Overview
11.9.3 ILIAS Biologics Extracellular Vesicle Therapy Introduction
11.9.4 ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.9.5 ILIAS Biologics Recent Development
11.10 Rion
11.10.1 Rion Company Details
11.10.2 Rion Business Overview
11.10.3 Rion Extracellular Vesicle Therapy Introduction
11.10.4 Rion Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.10.5 Rion Recent Development
11.11 SHIFTBIO
11.11.1 SHIFTBIO Company Details
11.11.2 SHIFTBIO Business Overview
11.11.3 SHIFTBIO Extracellular Vesicle Therapy Introduction
11.11.4 SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (2019-2024)
11.11.5 SHIFTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Extracellular Vesicle Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Exosome-based
Table 3. Key Players of Microvesicle-based
Table 4. Global Extracellular Vesicle Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Extracellular Vesicle Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Extracellular Vesicle Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Extracellular Vesicle Therapy Market Share by Region (2019-2024)
Table 8. Global Extracellular Vesicle Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Extracellular Vesicle Therapy Market Share by Region (2025-2030)
Table 10. Extracellular Vesicle Therapy Market Trends
Table 11. Extracellular Vesicle Therapy Market Drivers
Table 12. Extracellular Vesicle Therapy Market Challenges
Table 13. Extracellular Vesicle Therapy Market Restraints
Table 14. Global Extracellular Vesicle Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Extracellular Vesicle Therapy Market Share by Players (2019-2024)
Table 16. Global Top Extracellular Vesicle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Vesicle Therapy as of 2023)
Table 17. Ranking of Global Top Extracellular Vesicle Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Extracellular Vesicle Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Extracellular Vesicle Therapy, Headquarters and Area Served
Table 20. Global Key Players of Extracellular Vesicle Therapy, Product and Application
Table 21. Global Key Players of Extracellular Vesicle Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Extracellular Vesicle Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Extracellular Vesicle Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Extracellular Vesicle Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Extracellular Vesicle Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Extracellular Vesicle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Extracellular Vesicle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Extracellular Vesicle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Extracellular Vesicle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Extracellular Vesicle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Extracellular Vesicle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. FUJIFILM Diosynth Biotechnologies Company Details
Table 47. FUJIFILM Diosynth Biotechnologies Business Overview
Table 48. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Product
Table 49. FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 50. FUJIFILM Diosynth Biotechnologies Recent Development
Table 51. EV Therapeutics Company Details
Table 52. EV Therapeutics Business Overview
Table 53. EV Therapeutics Extracellular Vesicle Therapy Product
Table 54. EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 55. EV Therapeutics Recent Development
Table 56. Cellular Biomedicine Group Company Details
Table 57. Cellular Biomedicine Group Business Overview
Table 58. Cellular Biomedicine Group Extracellular Vesicle Therapy Product
Table 59. Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 60. Cellular Biomedicine Group Recent Development
Table 61. Codiak BioSciences Company Details
Table 62. Codiak BioSciences Business Overview
Table 63. Codiak BioSciences Extracellular Vesicle Therapy Product
Table 64. Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 65. Codiak BioSciences Recent Development
Table 66. Coya Therapeutics Company Details
Table 67. Coya Therapeutics Business Overview
Table 68. Coya Therapeutics Extracellular Vesicle Therapy Product
Table 69. Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 70. Coya Therapeutics Recent Development
Table 71. Curexsys Company Details
Table 72. Curexsys Business Overview
Table 73. Curexsys Extracellular Vesicle Therapy Product
Table 74. Curexsys Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 75. Curexsys Recent Development
Table 76. Evox Therapeutics Company Details
Table 77. Evox Therapeutics Business Overview
Table 78. Evox Therapeutics Extracellular Vesicle Therapy Product
Table 79. Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 80. Evox Therapeutics Recent Development
Table 81. ExoCoBio Company Details
Table 82. ExoCoBio Business Overview
Table 83. ExoCoBio Extracellular Vesicle Therapy Product
Table 84. ExoCoBio Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 85. ExoCoBio Recent Development
Table 86. ILIAS Biologics Company Details
Table 87. ILIAS Biologics Business Overview
Table 88. ILIAS Biologics Extracellular Vesicle Therapy Product
Table 89. ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 90. ILIAS Biologics Recent Development
Table 91. Rion Company Details
Table 92. Rion Business Overview
Table 93. Rion Extracellular Vesicle Therapy Product
Table 94. Rion Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 95. Rion Recent Development
Table 96. SHIFTBIO Company Details
Table 97. SHIFTBIO Business Overview
Table 98. SHIFTBIO Extracellular Vesicle Therapy Product
Table 99. SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (2019-2024) & (US$ Million)
Table 100. SHIFTBIO Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report


List of Figures
Figure 1. Extracellular Vesicle Therapy Picture
Figure 2. Global Extracellular Vesicle Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Extracellular Vesicle Therapy Market Share by Type: 2023 VS 2030
Figure 4. Exosome-based Features
Figure 5. Microvesicle-based Features
Figure 6. Global Extracellular Vesicle Therapy Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Extracellular Vesicle Therapy Market Share by Application: 2023 VS 2030
Figure 8. Cancer Treatment Case Studies
Figure 9. Regenerative Medicine Case Studies
Figure 10. Drug Delivery Case Studies
Figure 11. Other Case Studies
Figure 12. Extracellular Vesicle Therapy Report Years Considered
Figure 13. Global Extracellular Vesicle Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Extracellular Vesicle Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Extracellular Vesicle Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Extracellular Vesicle Therapy Market Share by Players in 2023
Figure 17. Global Top Extracellular Vesicle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Vesicle Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Extracellular Vesicle Therapy Revenue in 2023
Figure 19. North America Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Extracellular Vesicle Therapy Market Share by Country (2019-2030)
Figure 21. United States Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Extracellular Vesicle Therapy Market Share by Country (2019-2030)
Figure 25. Germany Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Extracellular Vesicle Therapy Market Share by Region (2019-2030)
Figure 33. China Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Extracellular Vesicle Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Extracellular Vesicle Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Extracellular Vesicle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 49. EV Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 50. Cellular Biomedicine Group Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 51. Codiak BioSciences Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 52. Coya Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 53. Curexsys Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 54. Evox Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 55. ExoCoBio Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 56. ILIAS Biologics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 57. Rion Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 58. SHIFTBIO Revenue Growth Rate in Extracellular Vesicle Therapy Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies